CD Biosynsis offers expert Chlamydomonas reinhardtii Pathway Optimization Services, leveraging the power of synthetic biology to maximize the metabolic potential of this premier photosynthetic model. Chlamydomonas, known as the "green yeast," is a versatile platform for producing high-value bioproducts, from biofuels and pigments to therapeutic recombinant proteins. Our service integrates precision genome editing (CRISPR-Cas9, Base Editing, CRISPRi) with metabolic flux analysis to identify and overcome bottlenecks in complex algal pathways. By balancing the flux between primary photosynthesis and secondary metabolism, we deliver optimized algal strains with significantly enhanced specific productivity and robust growth characteristics.
Get a QuoteOptimizing pathways in Chlamydomonas reinhardtii requires a deep understanding of the interplay between the nuclear and chloroplast genomes. Our platform addresses the unique challenges of algal engineering, such as the high GC-content and robust gene silencing, to ensure stable and predictable pathway performance. We utilize a "Design-Build-Test-Learn" cycle to iteratively refine metabolic routes. Whether you are seeking to redirect carbon from starch to lipids or enhance the secretion of a complex protein, our integrated approach provides the genomic precision and analytical depth required to achieve peak cellular performance.
Carbon Flux Redirection
Utilizing CRISPR-Cas9 to knockout starch biosynthesis genes (e.g., STA6) to force carbon flux into triacylglycerol (TAG) production.
Enzyme Fine-Tuning
Applying Base Editing or CRISPRi to tune the expression of rate-limiting enzymes like DGAT to enhance lipid accumulation without compromising cell viability.
LHC Antenna Reduction
Knocking down light-harvesting complex (LHC) genes to reduce chlorophyll content, improving light penetration in high-density cultures and reducing photo-inhibition.
CCM Optimization
Engineering the Carbon Concentrating Mechanism (CCM) to improve CO2 fixation rates under ambient conditions, boosting overall biomass yield.
Secretion Pathway Tuning
Optimization of signal peptides and chaperone expression to facilitate the efficient folding and secretion of humanized therapeutic proteins into the culture medium.
Protease Knockout
Targeted deletion of endogenous proteases to prevent the degradation of secreted recombinant products, ensuring high-quality protein recovery.
Our systematic workflow combines computational modeling with high-efficiency genetic tools.
1. Flux Analysis & Design
2. Multi-Locus Engineering
3. HTS & Phenotyping
4. Stability & Verification
Utilizing Genome-Scale Metabolic Models (GEMs) to identify bottlenecks and metabolic competition. Design of gRNAs and donor templates for multi-gene modification.
Simultaneous nuclear and chloroplast editing via RNP delivery and biolistic transformation. Implementation of multiplexed CRISPRi for branched pathway control.
Verification: Confirming genotype via NGS and metabolic stability over 30+ passages. Delivery of optimized strains and comprehensive flux reports.
Cross-Genomic Engineering
Expertise in simultaneously optimizing nuclear-encoded host factors and chloroplast-encoded photosynthetic subunits for total pathway control.
Flux-Driven Design
Our strategies are based on predictive metabolic modeling (FBA), ensuring that every genetic edit contributes to the desired metabolic outcome.
Tunable Gene Control
Access to CRISPRi and Base Editing allows for subtle, non-lethal tuning of gene expression, essential for balancing complex metabolic fluxes.
Optimized Algal Chassis
A deep library of validated algal promoters, terminators, and introns ensures high-level transgene performance in the 64% GC environment.
1. Why is pathway optimization in Chlamydomonas more complex than in yeast?
Complexity arises from the three-genome system (nucleus, chloroplast, mitochondria) and the high GC-bias. Coordinating flux across these compartments requires specialized targeting and codon optimization.
2. Can you optimize a pathway that requires chloroplast-localized enzymes?
Yes. We can either integrate genes directly into the chloroplast genome via biolistics or use nuclear integration with specialized chloroplast-targeting signals (CTP).
3. How do you ensure the optimized phenotype doesn't revert?
We prioritize site-specific integration into validated genomic safe harbors and perform long-term stability trials (30+ passages) to ensure consistent performance.
4. What role does CRISPRi play in optimization?
CRISPRi is essential for knocking down genes that compete for carbon or energy but are essential for survival, allowing us to find the "sweet spot" of repression for maximal flux.
5. Do you provide metabolic flux quantification?
Yes, we offer analytical services including GC-MS, HPLC, and 13C-labeling experiments to quantify actual flux changes in the optimized strains.
6. How do you handle the high GC-content of the Chlamydomonas genome?
We utilize nuclease variants and gRNA design tools specifically optimized for high-GC environments and employ full-gene synthesis with algal codon bias.
7. Is it possible to enhance photosynthetic CO2 uptake?
Absolutely. We target components of the Carbon Concentrating Mechanism (CCM), such as carbonic anhydrases and bicarbonate transporters, to boost carbon availability for Rubisco.
8. What is the typical lead time for a pathway optimization project?
Depending on complexity (number of genes and compartments), projects typically range from 16 to 24 weeks from initial modeling to delivered strain.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.